Federal Register / Vol. 87, No. 71 / Wednesday, April 13, 2022 / Notices 21923 

1The record is defined in § 207.2(f) of the 

Commission’s Rules of Practice and Procedure (19 

CFR 207.2(f)). 

2 87 FR 9576 (February 22, 2022). 

3The Coalition is composed of JLG Industries, 

Inc. (‘‘JLG’’), Hagerstown, Maryland and Terex 

Corp. (‘‘Terex’’), Redmond, Washington. 

4 86 FR 57809 (October 19, 2021). 

5 86 FR 70147 (December 9, 2021). 

6 87 FR 9576 (February 22, 2022). 

number of persons wishing to speak, 

and the time available, the time for 

individual comments may be limited. 

Any written comments received will be 

provided to the AMWG members. 

Before including your address, phone 

number, email address, or other 

personal identifying information in your 

comment, you should be aware that 

your entire comment—including your 

personal identifying information—may 

be made publicly available at any time. 

While you can ask us in your 

comment to withhold your personal 

identifying information from public 

review, we cannot guarantee that we 

will be able to do so. 

Authority: 5 U.S.C. appendix 2. 

Lee Traynham, 

Chief, Adaptive Management Group, 

Resources Management Division, Upper 

Colorado Basin—Interior Region 7. 

[FR Doc. 2022–07860 Filed 4–12–22; 8:45 am] 

BILLING CODE 4332–90–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 731–TA–1557 (Final)] 

Certain Mobile Access Equipment and 

Subassemblies Thereof From China 

Determination 

On the basis of the record 1 developed 

in the subject investigation, the United 

States International Trade Commission 

(‘‘Commission’’) determines, pursuant 

to the Tariff Act of 1930 (‘‘the Act’’), 

that an industry in the United States is 

threatened with material injury by 

reason of imports of certain mobile 

access equipment and subassemblies 

thereof (‘‘mobile access equipment’’) 

from China, provided for in subheadings 

8427.10.80, 8427.20.80, 8427.90.00, and 

8431.20.00 of the Harmonized Tariff 

Schedule of the United States, that have 

been found by the U.S. Department of 

Commerce (‘‘Commerce’’) to be sold in 

the United States at less than fair value 

(‘‘LTFV’’).2

Background 

The Commission instituted this 

investigation effective February 26, 

2021, following receipt of antidumping 

and countervailing duty petitions filed 

with the Commission and Commerce by 

the Coalition of American 

Manufacturers of Mobile Access 

Equipment (‘‘CAMMAE’’ or ‘‘the 

Coalition’’).3 The Commission 

scheduled the final phase of these 

investigations following notification of a 

preliminary determination by 

Commerce that imports of mobile access 

equipment from China were being 

subsidized within the meaning of 

section 703(b) of the Act (19 U.S.C. 

1671b(b)). Notice of the scheduling of 

the final phase of the Commission’s 

investigations and of a public hearing to 

be held in connection therewith was 

given by posting copies of the notice in 

the Office of the Secretary, U.S. 

International Trade Commission, 

Washington, DC, and by publishing the 

notice in the Federal Register of August 

12, 2021 (86 FR 44402). In light of the 

restrictions on access to the Commission 

building due to the COVID–19 

pandemic, the Commission conducted 

its hearing through written testimony 

and video conference on October 12, 

2021. All persons who requested the 

opportunity were permitted to 

participate. 

The investigation schedules became 

staggered when Commerce did not align 

its countervailing duty investigation 

with its antidumping duty investigation. 

Following notification of a final 

determination by Commerce that 

imports of mobile access equipment 

from China were being subsidized 

within the meaning of section 705(a) of 

the Act (19 U.S.C. 1671d(a)),4 on 

December 3, 2021, the Commission 

issued a final affirmative determination 

in its countervailing duty investigation 

of mobile access equipment from 

China.5 Following notification of a final 

determination by Commerce that 

imports of mobile access equipment 

from China were being sold at LTFV 

within the meaning of section 735(a) of 

the Act (19 U.S.C. 1673d(a)),6 notice of 

the supplemental scheduling of the final 

phase of the Commission’s antidumping 

duty investigation was given by posting 

copies of the notice in the Office of the 

Secretary, U.S. International Trade 

Commission, Washington, DC, and by 

publishing the notice in the Federal 

Register of March 2, 2022 (87 FR 

11730). 

The Commission made this 

determination pursuant to § 735(b) of 

the Act (19 U.S.C. 1673d(b)). It 

completed and filed its determination in 

this investigation on April 8, 2022. The 

views of the Commission are contained 

in USITC Publication 5317 (April 2022), 

entitled Certain Mobile Access 

Equipment and Subassemblies Thereof 

from China: Investigation No. 731–TA– 

1557 (Final). 

By order of the Commission. 

Issued: April 8, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–07912 Filed 4–12–22; 8:45 am] 

BILLING CODE 7020–02–P 

INTERNATIONAL TRADE 

COMMISSION 

[Investigation No. 337–TA–1238] 

Certain Plant-Derived Recombinant 

Human Serum Albumins (‘‘rHSA’’) and 

Products Containing Same; Notice of 

Request for Submissions on the Public 

Interest 

AGENCY: U.S. International Trade 

Commission. 

ACTION: Notice. 

SUMMARY: Notice is hereby given that on 

April 7, 2022, the presiding 

administrative law judge (‘‘ALJ’’) issued 

an Initial Determination on Violation of 

Section 337. The ALJ also issued a 

Recommended Determination on 

remedy and bonding should a violation 

be found in the above-captioned 

investigation. The Commission is 

soliciting submissions on public interest 

issues raised by the recommended relief 

should the Commission find a violation. 

This notice is soliciting comments from 

the public only. 

FOR FURTHER INFORMATION CONTACT: 

Ronald A. Traud, Esq., Office of the 

General Counsel, U.S. International 

Trade Commission, 500 E Street SW, 

Washington, DC 20436, telephone (202) 

205–3427. Copies of non-confidential 

documents filed in connection with this 

investigation may be viewed on the 

Commission’s electronic docket (EDIS) 

at https://edis.usitc.gov. For help 

accessing EDIS, please email 

EDIS3Help@usitc.gov. General 

information concerning the Commission 

may also be obtained by accessing its 

internet server at https://www.usitc.gov. 

Hearing-impaired persons are advised 

that information on this matter can be 

obtained by contacting the 

Commission’s TDD terminal on (202) 

205–1810. 

SUPPLEMENTARY INFORMATION: Section 

337 of the Tariff Act of 1930 provides 

that, if the Commission finds a 

violation, it shall exclude the articles 

concerned from the United States: 

Unless, after considering the effect of 

such exclusion upon the public health 

and welfare, competitive conditions in 


jspears on DSK121TN23PROD with NOTICES1
21924 Federal Register / Vol. 87, No. 71 / Wednesday, April 13, 2022 / Notices 

the United States economy, the 

production of like or directly 

competitive articles in the United 

States, and United States consumers, it 

finds that such articles should not be 

excluded from entry. 19 U.S.C. 

1337(d)(1). A similar provision applies 

to cease and desist orders. 19 U.S.C. 

1337(f)(1). 

The Commission is soliciting 

submissions on public interest issues 

raised by the recommended relief 

should the Commission find a violation, 

specifically: A limited exclusion order 

directed to certain plant-derived 

recombinant human serum albumins 

(‘‘rHSA’’) and products containing 

imported, sold for importation, and/or 

sold after importation by respondents 

Wuhan Healthgen Biotechnology Corp. 

of Wuhan, China; Aspira Scientific, Inc. 

of Milpitas, California (‘‘Aspira’’); 

eEnzyme LLC of Gaithersburg, Maryland 

(‘‘eEnzyme’’); and ScienCell Research 

Laboratories, Inc., of Carlsbad, 

California (‘‘ScienCell’’); and cease and 

desist orders directed to Aspira, 

eEnzyme, and ScienCell. Parties are to 

file public interest submissions 

pursuant to 19 CFR 210.50(a)(4). 

The Commission is interested in 

further development of the record on 

the public interest in this investigation. 

Accordingly, members of the public are 

invited to file submissions of no more 

than five (5) pages, inclusive of 

attachments, concerning the public 

interest in light of the ALJ’s 

Recommended Determination on 

Remedy and Bonding issued in this 

investigation on April 7, 2022. 

Comments should address whether 

issuance of the recommended remedial 

orders in this investigation, should the 

Commission find a violation, would 

affect the public health and welfare in 

the United States, competitive 

conditions in the United States 

economy, the production of like or 

directly competitive articles in the 

United States, or United States 

consumers. 

In particular, the Commission is 

interested in comments that: 

(i) Explain how the articles 

potentially subject to the recommended 

remedial orders are used in the United 

States; 

(ii) identify any public health, safety, 

or welfare concerns in the United States 

relating to the recommended orders; 

(iii) identify like or directly 

competitive articles that complainant, 

its licensees, or third parties make in the 

United States which could replace the 

subject articles if they were to be 

excluded; 

(iv) indicate whether complainant, 

complainant’s licensees, and/or thirdparty suppliers have the capacity to 

replace the volume of articles 

potentially subject to the recommended 

orders within a commercially 

reasonable time; and 

(v) explain how the recommended 

orders would impact consumers in the 

United States. 

Written submissions must be filed no 

later than by close of business on May 

9, 2022. 

Persons filing written submissions 

must file the original document 

electronically on or before the deadlines 

stated above. The Commission’s paper 

filing requirements in 19 CFR 210.4(f) 

are currently waived. 85 FR 15798 (Mar. 

19, 2020). Submissions should refer to 

the investigation number (‘‘Inv. No. 

337–TA–1238’’) in a prominent place on 

the cover page and/or the first page. (See 

Handbook for Electronic Filing 

Procedures, https://www.usitc.gov/ 

documents/handbook_on_filing_

procedures.pdf.). Persons with 

questions regarding filing should 

contact the Secretary (202–205–2000). 

Any person desiring to submit a 

document to the Commission in 

confidence must request confidential 

treatment by marking each document 

with a header indicating that the 

document contains confidential 

information. This marking will be 

deemed to satisfy the request procedure 

set forth in Rules 201.6(b) and 

210.5(e)(2) (19 CFR 201.6(b) & 

210.5(e)(2)). Documents for which 

confidential treatment by the 

Commission is properly sought will be 

treated accordingly. Any non-party 

wishing to submit comments containing 

confidential information must serve 

those comments on the parties to the 

investigation pursuant to the applicable 

Administrative Protective Order. A 

redacted non-confidential version of the 

document must also be filed 

simultaneously with any confidential 

filing and must be served in accordance 

with Commission Rule 210.4(f)(7)(ii)(A) 

(19 CFR 210.4(f)(7)(ii)(A)). All 

information, including confidential 

business information and documents for 

which confidential treatment is properly 

sought, submitted to the Commission for 

purposes of this investigation may be 

disclosed to and used: (i) By the 

Commission, its employees and Offices, 

and contract personnel (a) for 

developing or maintaining the records 

of this or a related proceeding, or (b) in 

internal investigations, audits, reviews, 

and evaluations relating to the 

programs, personnel, and operations of 

the Commission including under 5 

U.S.C. Appendix 3; or (ii) by U.S. 

government employees and contract 

personnel, solely for cybersecurity 

purposes. All contract personnel will 

sign appropriate nondisclosure 

agreements. All nonconfidential written 

submissions will be available for public 

inspection on EDIS. 

This action is taken under the 

authority of section 337 of the Tariff Act 

of 1930, as amended (19 U.S.C. 1337), 

and in Part 210 of the Commission’s 

Rules of Practice and Procedure (19 CFR 

part 210). 

By order of the Commission. 

Issued: April 8, 2022. 

Lisa Barton, 

Secretary to the Commission. 

[FR Doc. 2022–07904 Filed 4–12–22; 8:45 am] 

BILLING CODE 7020–02–P 

DEPARTMENT OF LABOR 

Agency Information Collection 

Activities; Submission for OMB 

Review; Comment Request, the 

Substance Use-Disorder Prevention 

That Promotes Opioid Recovery and 

Treatment for Patients and 

Communities (SUPPORT) Act Grants 

Evaluation, New Collection 

AGENCY: Office of the Assistant 

Secretary for Policy, Chief Evaluation 

Office, Department of Labor. 

ACTION: Notice of information collection; 

request for comment. 

SUMMARY: The Department of Labor 

(DOL), as part of its continuing effort to 

reduce paperwork and respondent 

burden, conducts a preclearance 

consultation program to provide the 

general public and federal agencies with 

an opportunity to comment on proposed 

and/or continuing collections of 

information in accordance with the 

Paperwork Reduction Act of 1995 

(PRA95). This program helps to ensure 

that requested data can be provided in 

the desired format, reporting burden 

(time and financial resources) is 

minimized, collection instruments are 

clearly understood, and the impact of 

collection requirements on respondents 

is properly assessed. Currently, the 

Department of Labor is soliciting 

comments concerning the collection of 

data about the SUPPORT Act Grant 

Program Evaluation. A copy of the 

proposed Information Collection 

Request (ICR) can be obtained by 

contacting the office listed below in the 

addressee section of this notice. 

DATES: Written comments must be 

submitted to the office listed in the 

ADDRESSES section below on or before 

June 13, 2022. 

ADDRESSES: You may submit comments 

by either one of the following methods: 


jspears on DSK121TN23PROD with NOTICES1